Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Nvidia Options Price in $280 Billion Earnings Swing 
SK Hynix Shares Fall as Workers Reject Wage Deal 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Shein Launches $1.77 Billion Hong Kong IPO After Years of Listing Delays 
Ampol Profit Surges as Refining Margins Hit Record Highs 
Tesla Raises Cybertruck Prices by $5,000 in US 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 
California Seeks Paramount Divestitures in Warner Bros. Merger 
Add as a preferred source on Google
EMERYVILLE, Calif., May 03, 2018 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner, Firmenich, to support the development and commercialization of Z11. This sustainable and cost-effective version of Firmenich’s iconic Z11 molecule was developed using Amyris’s disruptive proprietary technology to develop a reliable and sustainable supply of an intermediate, using a fermentation-based production process, for which Firmenich has then applied its state of the art, proprietary green chemistry.
“We are pleased with our ability to support Firmenich’s product innovation as they continue to be a leader in developing game-changing ingredients for their customers,” said John Melo, President & CEO of Amyris. “Amyris has collaborated with Firmenich since 2010, successfully growing a palette of bio-based fragrance ingredients and intermediates as Firmenich continues their legacy of providing the finest ingredients well into the future, with the added benefit of being derived from a sustainable resource.”
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. More information about the company is available at www.amyris.com.
Amyris and the Amyris logo are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. All other trademarks are the property of their respective owners.
Contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris, Inc.
+1 (510) 740-7481
[email protected]
[email protected]
